Description of use

ProFound AI® Risk is the world’s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram.

The easy-to-implement solution provides superior insights that empower clinicians to tailor a woman’s breast screening regimen and potentially identify cancers earlier.

ProFound AI Risk uniquely combines a range of risk factors, offering superior performance and accuracy in assessing short-term risk compared to traditional, commonly-used breast cancer risk models.

• Flexibility to calculate a one, two, or three-year absolute risk and risk category for the woman and compares her risk relative to the average risk for women in her age group (country specific).
• Designed to offer greater accuracy and ethnically inclusive precision screening.
• More than 15 country-specific incidence and mortality rates for alignment with the country’s general population.

ProFound AI Risk is CE Marked and Health Canada Licensed. Not available in US.